SCHEMBL19620132

SCHEMBL19620132

COC(=O)N[C@@H](C(=O)N1CC=C[C@H]1c1nc(-c2ccc(-c3ccc(-c4c[nH]c([C@@H]5C=CCN5C(=O)[C@H](NC(=O)OC)c5ccccc5)n4)cc3)cc2)c[nH]1)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 3/20 0.47
▸ CYP3A4 P08684 10/20 0.38
▸ CYP2C9 P11712 9/20 0.38
▸ CYP2C19 P33261 6/20 0.38
▸ CYP2D6 P10635 4/20 0.38
▸ CYP1A2 P05177 3/20 0.38
▸ OPRK1 P41145 2/20 0.34
▸ TACR3 P29371 7/20 0.33
▸ TACR2 P21452 3/20 0.32
▸ TSHR P16473 2/20 0.32
▸ ALDH1A1 P00352 2/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ NFKB1 P19838 1/20 0.32
▸ MTOR P42345 1/20 0.32
▸ BLM P54132 1/20 0.32
▸ PMP22 Q01453 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17751542 1.00 KCNH2 (0.47) KCNH2CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL16282928 1.00 KCNH2 (0.47) KCNH2CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL16282904 1.00 KCNH2 (0.47) KCNH2CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL19618655 0.96 KCNH2 (0.43) KCNH2CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL18727069 0.95 KCNH2 (0.42) KCNH2CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL18727074 0.95 KCNH2 (0.42) KCNH2CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL16282777 0.95 KCNH2 (0.42) KCNH2CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL16282925 0.92 KCNH2 (0.50) KCNH2CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL17751541 0.92 KCNH2 (0.50) KCNH2CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL16282902 0.92 KCNH2 (0.50) KCNH2CYP3A4CYP2C9CYP2C19CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9820972-B2 Antiviral compounds highly effective as HCV-NS5A inhibitor AB Pharma Ltd. (CN) 2017-11-21 — — US disclosed
Send feedback